Advisor Group’s CorMedix CRMD Stock Holding History

Advisor Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Hold	400	–	–	﹤0.01%	4830
2019 Q3	$3K	Hold	400	–	–	﹤0.01%	4820
2019 Q2	$4K	Hold	400	–	–	﹤0.01%	4740
2019 Q1	$4K	Hold	400	–	–	﹤0.01%	4752
2018 Q4	$3K	Hold	400	–	–	﹤0.01%	4698
2018 Q3	$2K	Hold	400	–	–	﹤0.01%	4836
2018 Q2	$0	Hold	400	–	–	﹤0.01%	4941
2018 Q1	$0	Buy	+400	New	+$798	﹤0.01%	4965

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advisor Group's CRMD Position: Q4 2019 in Review

Advisor Group held its CorMedix (CRMD) position steady in Q4 2019 at 400 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4830.

Advisor Group first reported a position in CRMD in Q1 2018 and has held it in 8 quarters since. The position peaked at $4K in Q2 2019. 62 funds tracked by Wall St. Rank hold CRMD as of Q4 2019.

Advisor Group held 400 shares of CorMedix worth $3K as of Q4 2019.
Advisor Group left its CorMedix share count unchanged in Q4 2019.
CorMedix made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4830 holding.
Advisor Group first reported a position in CorMedix in Q1 2018 and has held it in 8 quarters since.
Advisor Group's CorMedix position peaked at $4K in Q2 2019.
62 funds tracked by Wall St. Rank held CorMedix as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.